These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9161531)

  • 21. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C. The surprise infectious disease of the decade.
    Mayo Clin Health Lett; 1998 Feb; 16(2):6. PubMed ID: 9516363
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute hepatitis C: a window of opportunity.
    Thomas DL
    Clin Infect Dis; 2006 Jun; 42(12):1671-3. PubMed ID: 16705569
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis C: be positively aware of the risk of transmission and treatment.
    Johnson B
    Posit Aware; 2002; 13(6):29-31. PubMed ID: 12484333
    [No Abstract]   [Full Text] [Related]  

  • 26. Anaesthesia for a patient on interferon therapy.
    Coleman M; Traynor C
    Acta Anaesthesiol Scand; 1999 Jan; 43(1):115-6. PubMed ID: 9926203
    [No Abstract]   [Full Text] [Related]  

  • 27. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy of hepatitis C: alpha interferon and ribavirin.
    Reichard O; Schvarcz R; Weiland O
    Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C: infection and current treatment strategies.
    Piascik P
    J Am Pharm Assoc (Wash); 1997; NS37(4):376-8. PubMed ID: 9519644
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatic transplantation and HBV reinfection].
    Xu X; Lu Z
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):75-6. PubMed ID: 11856518
    [No Abstract]   [Full Text] [Related]  

  • 31. Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy.
    Ono SK; da Silva LC; Carrilho FJ; da Fonseca LE; Mendes LC; Madruga CL; Farias Ade Q; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(5):180-3. PubMed ID: 9216095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    Farrell GC
    J Gastroenterol Hepatol; 2007 May; 22(5):607-10. PubMed ID: 17444844
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of chronic hepatitis C.
    Nelson DR; Davis GL
    Compr Ther; 1997 Apr; 23(4):269-76. PubMed ID: 9167919
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatitis C: natural history, biology, treatment monitoring].
    Poynard T
    Pathol Biol (Paris); 1999 Nov; 47(9):911-6. PubMed ID: 10609271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of hepatitis C: re-treatment with alpha interferon.
    Alberti A; Chemello L; Noventa F; Cavalletto L; De Salvo G
    Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S; McHutchison J
    Am J Gastroenterol; 2000 May; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C: treatment challenges.
    Copley L
    Prof Nurse; 2003 Nov; 19(3):133-4. PubMed ID: 14639900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hepatitis C--update 2005].
    Forestier N; Zeuzem S
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S215-6. PubMed ID: 16435713
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.